Clinical Significance of the Venous Occlusion Test on Systemic Lupus erythematosus Patients with a Focus on Changes in Blood Levels of Tissue Plasminogen Activator, von Willebrand Factor Antigen, and Thrombomodulin | Citedby Results | Acta Haematologica | Karger Publishers

Skip to Main Content

Skip Nav Destination

Clinical Significance of the Venous Occlusion Test on Systemic Lupus erythematosus Patients with a Focus on Changes in Blood Levels of Tissue Plasminogen Activator, von Willebrand Factor Antigen, and Thrombomodulin

Acta Haematol (1992) 88 (1): 22–26.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Changes to fibrinolysis in patients with systemic lupus erythematosus are associated with endothelial cell damage and inflammation, but not antiphospholipid antibodies

Parvinderjit K. Dhillon
Alhossain A. Khalafallah
Murray J. Adams

Blood Coagulation & Fibrinolysis (2016) 27 (8): 870.

Antiendothelial cell antibodies in systemic lupus erythematosus

Yves Renaudineau
Christophe Dugué
Maryvonne Dueymes
Pierre Youinou

Autoimmunity Reviews (2002) 1 (6): 365.

Thrombomodulin: An overview and potential implications in vascular disorders

M-C Boffa
M Karmochkine

Lupus (1998) 7 (2_suppl): 120.

Fibrinolysis and coagulation abnormalities in systemic lupus erythematosus

A. Doria
A. Ghirardello
M. Boscaro
M. L. Viero
E. Vaccaro
G. M. Patrassi
P. F. Gambari

Rheumatology International (1995) 14 (5): 207.

Medical Perspective Antiphospholipid Antibodies, Thrombosis and Atherosclerosis in Systemic Lupus Erythematosus: a Unifying 'Membrane Stress Syndrome' Hypothesis

Paul R.J. Ames

Lupus (1994) 3 (5): 371.